methyl({[3-(trifluoromethyl)pyridin-2-yl]methyl})amine dihydrochloride, 1g

4-Chloro-2-(trifluoromethyl)benzoic Acid>98.0%(GC)(T)5g

Ethyl azepane-4-carboxylate hydrochloride, 98%, 5g

9-Oxoacridine-10-acetic Acid>98.0%(HPLC)(T)5g

(1-Benzyl-pyrrolidin-3-yl)-isopropyl-amine, 500mg

tert-Butyl 1,8-diazaspiro[4.5]decane-8-carboxylate hydrochloride, 97%, 100mg

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 1g

Benzyl prop-2-yn-1-ylcarbamate, 95.0%, 1g

N-(Prop-2-yn-1-yl)acrylamide, 97%, 5g

(Trimethoxymethyl)benzene, 95.0%, 25g

Ruthenium ICP standard solution, ROTI®Star, 1000 mg/l Ru, density (D) 1.012 g/cm³

4H-Cyclopenta[2,1-b:3,4-b']dithiophene>97.0%(GC)1g

(2E)-3-(3-bromophenyl)-1-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 2g